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ABSTRACT
Bacillus anthracis is a bacterial pathogen of great importance, both historically
and in the present. Despite this importance, many questions remain regarding defending
against its use as a biological weapon, the bacteria’s variation in virulence, and its
epidemiology in nature.
Using Etest strips (AB BIODISK, Solna, Sweden) to measure the minimum
inhibition concentrations (MICs), 25 genetically diverse isolates of B. anthracis were
tested to determine their susceptibility to seven clinically relevant antimicrobial agents.
Using the National Committee for Clinical Laboratory Standards (NCCLS) MIC
breakpoints for staphylococci, three isolates were found to be resistant to penicillin and
negative for beta-lactamase production.
From a group of investigations, results indicated B. anthracis virulence is related
to clonality and the copy numbers per cell of the virulence plasmids, pXO1 and pXO2.
Isolates were characterized with respect to their plasmid copy number (pXO1/2) using a
novel method of quantitative PCR and the numbers differ greatly from previous reports.
Anthrax Vaccine with Adjuvant (AVA) vaccinated guinea pigs were challenged with 20
B. anthracis strains representative of worldwide genetic diversity. A virulence model
was constructed by combining the survival, plasmid copy number, and genotyping (based
on multilocus variable number tandem repeat analysis typing) data of each isolate. The
model obtained was validated using a randomly chosen set of 12 B. anthracis isolates and
verified model robustness.

ix

Two carcass disposal methods, incineration and burial, are recommended to
decrease or prevent environmental spore contamination. The extent of contamination
from an anthrax carcass is almost totally unknown in either method of disposal. Studies
of environmental contamination by spores of B. anthracis from infected carcasses have
only recently been possible because of new technologies. A method utilizing real-time
quantitative PCR was developed to quantitate B. anthracis in environmental samples.
Absolute quantitation was made possible by the use of clones. This method has allowed
the evaluation of the environmental contamination by the different carcass disposal
methods and by scavenging of the carcass. The results support the complete burning of a
carcass soon after death as the method choice to decrease environmental contamination
for the disposal of anthrax affected carcasses.

x

CHAPTER ONE
GENERAL INTRODUCTION
1.1. Background
Anthrax is an acute bacterial disease of primarily herbivores, which is
transmissible to humans. The etiologic agent, Bacillus anthracis, is a gram-positive
spore forming rod shaped bacterium. Animals become infected by ingesting spores or
possibly by being bitten by flies that have fed on an infected animal or carcass (7).
Infected animals are usually found dead as death can occur within 24 hours. (27).
Anthrax can be found worldwide affecting wildlife, livestock, and humans.
During epidemics in 1959/60 and 1970 in the Kruger National Park, South Africa,
anthrax deaths numbered in the thousands (4). Livestock cases are known to contribute
to human cases through the cutaneous gastrointestinal and inhalation route. In 2000, the
first gastrointestinal cases were reported in the United States after the family ate beef
from an infected carcass (5).
In North America in the year 2000, 413 livestock cases were confirmed and in the
year 2001, 795 (Table 1.1). For every confirmed anthrax case, it is estimated that at least
five cases go unreported. Though an effective vaccine for anthrax does exist and is
obtainable through a veterinarian, it is often not used until an epidemic occurs. Vaccine
complacency seems to arise after three to five years of vaccine use.
Although environmental contamination with B. anthracis spores occurs because
of wildlife and domestic livestock cases, the degree or level of contamination from each
case is unknown. Anthrax spores are known to persist in the environment for years and
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are resistant to environmental factors (19). Spores may be found in soil contaminated by
diseased animals or in diseased animal products such as hair, wool, hides, and bones (2,
12). Very little research has been done on anthrax spore survival under natural
conditions.
Table 1.1 Reported livestock deaths in North America for the years 2000 and 2001
Location
Reported Anthrax Livestock Deaths
Year 2000
Year 2001
WBNP, Canada
105
83
Alberta, Canada
0
12
Hook Lake, Canada
0
11
Manitoba, Canada
30
9
Nevada
83
0
N. Dakota
150
5
S. Dakota
15
11
Minnesota
25
88
Texas
0
555
California
0
21
Cuidad Acuna, Mexico
5
0
Total
413
795
To prevent or decrease the number of spores contaminating an area, several
methods of carcass disposal have been suggested and utilized. These methods, including
incineration, burial, or rendering of the carcass, are recommended with no scientific data
to back them. Once a site becomes seeded with spores, the disease becomes enzootic or
at a constant risk of a persistent series of outbreaks, and sporadic occurrences of the
disease occur in susceptible animals (26).
A search of the literature shows little work has been done to ascertain the level of
contamination from a carcass regardless of the manner of carcass disposal. Spores are
known to survive in the environment for years (19). The worldwide distribution of
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anthrax and the difficulty encountered in combating it is the result of the marvelous
tenacity of the anthrax spore (17). Spores prepared by Pasteur in 1888 were found to be
viable 68 years later. Bones recovered in the Kruger National Park and estimated by
carbon dating to be 200±50 years old are reported to have yielded B. anthracis on culture
(4). Recent studies on the ecology of anthrax have reported a correlation between the
disease and specific soil factors, such as alkaline pH, high moisture, and high organic
content (16, 23, 24). Review of the properties of spores of B. anthracis suggests that the
specific soil factors linked to epidemic areas reflect important environmental conditions
that aid the anthrax spores in causing epidemics (6). The Office International Des
Epizooties (OIE) and World Health Organization (WHO) Anthrax Guidelines
recommend incineration of infected carcasses as the most desirable method of disposal
followed by rendering and then by deep burial of the carcass after covering it with
quicklime (1, 15, 20). Nothing definitive exists in the literature quantifying or comparing
environmental contamination by carcass disposal methods.
1.2. Significance of the Work
The 2000 and 2001 North American epidemics raised many questions. Questions
about how to treat, vaccinate, quarantine, and dispose of the carcasses were asked by
everyone from the farm hand to the veterinarian and the department of public health.
Treatment, vaccination, and quarantine were handled by the attending veterinarian in
collaboration with the responsible public health departments. However, there was still
the question of carcass disposal, which is an interesting dilemma.
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Incineration is thought to be the best way to dispose of the carcass and reduce or
eliminate contamination by the anthrax spores. However, there exist many problems with
the incineration of carcasses. Most cases occur in July and August in geographical areas
that are very dry and have a high fire risk. The labor and materials to burn a 2000-pound
carcass can be prohibitive, especially if there are several deaths.
Burial is another option that is suggested especially for high-risk fire areas. Also
prior to backfilling, ‘experts’ suggests that quicklime be poured over the carcasses. Yet
again burial raises many questions regarding how, where, and what to bury. No
guidelines exist on how deep to bury a carcass and how much quicklime should be
applied, though suggestions and opinions abound.
C.D. Stein first suggested quicklime for use in the 1950s though no reason was
given (18). Recently, it has been proven that more cases occur in calcium rich soil, and
as quicklime is a calcium based agent there seems to be no logic supporting this
suggestion (16). High levels of calcium in the soil may buffer the spores’ supply of
calcium and help maintain the spores viability in the environment for longer periods of
time, thereby increasing their chances of coming into contact with and successfully
infecting new hosts (14, 16).
Also questions regarding single or group burial are numerous. The burial of each
carcass where it lay would be the logical choice, but, if there are several cases, group
burial may be more appropriate. Group burial presents its own problems with
transportation of carcasses and contamination.
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In some areas where anthrax occurs, neither burning nor burial is a viable option.
WBNP is a prime example of such an area as their cases are usually found by fire spotters
flying over the park. The carcasses are usually found in remote areas inaccessible except
by helicopter or all terrain vehicles. Getting the equipment necessary for the burial of a
two-ton bull buffalo carcass into these areas is impossible.
Unless carcasses are found and disposed of quickly, scavenging occurs from
buzzards, canines, felines, and other wildlife. Scavenging should be kept to a minimum
as the scavengers help contaminate the environment. Scavengers open the carcass, which
allows more sporulation to occur by releasing the vegetative organism from the acidic
environment of the decaying carcass, thereby, enabling it to sporulate. Scavengers are
not as susceptible to anthrax as herbivores; hence; after eating the diseased carcass spread
spores in their feces.
Public health departments and liable parties are interested in environmental
contamination not just for the possible re-infection of livestock but also for liability and
safety reasons. Many acres of pastureland are fast becoming urban ranchettes, and some
of this pastureland is known as an anthrax area. They need to know about contamination
for risk assessment purposes. They want to know the risk of building homes and
apartments in areas where anthrax infected carcasses have been disposed and the risk of
human infection in these areas.
These arguments lead to the question of what is the best disposal method of
anthrax carcasses and how much contamination can be expected utilizing each method.
The answers will provide scientific data on which to base a decision.
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The virulence of B. anthracis is associated with two megaplasmids, and isolates
lacking either plasmid are either avirulent or significantly attenuated. Plasmid pXO2 (60
MDa) carries genes required for the synthesis of an antiphagocytic poly-D-glutamic acid
capsule (8, 10, 13, 21, 22, 25). The 110-MDa plasmid pXO1 is required for synthesis of
the anthrax toxin proteins, edema factor (EF), lethal factor (LF), and protective antigen
(PA) (21). These proteins act in binary combinations to produce the two anthrax toxins:
edema toxin (a protective antigen and edema factor) and lethal toxin (a protective antigen
and lethal factor) (11). Despite the important roles of pXO1 and pXO2 in B. anthracis
virulence, it has always been assumed that each plasmid is represented once in a bacterial
cell.
The original scope of this thesis was the environmental contamination posed by
anthrax carcass disposal. During the controlled studies and preparation of the 5’ nuclease
assay it was discovered that plasmid to chromosome ratio was 1:1:1. This discovery led
to a study to quantitate the number of plasmids per bacteria.
The bioterrorism events in the Northeast United States in October 2001 also
changed the scope of this work, as the event involved the mailing of anthrax spores. The
first cases of inhalation and cutaneous anthrax resulting from the intentional release of B.
anthracis were seen with this event (3, 9). This attack offered a tragic proof of principle
of the danger of B. anthracis and has spurred numerous efforts by the biological
community to improve forensics and medical countermeasures against the bacterium.
My contribution to the immediate threat was an antimicrobial panel against 25
geographically and genetically diverse B. anthracis isolates to assess minimum inhibitory
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concentrations. This panel consisted of penicillin, cephalexin, cefaclor, tobramycin,
doxycycline, ciprofloxacin, and cefuroxime.
1.3. Hypotheses
1. A difference in antimicrobial minimum inhibitory concentrations (MICs)
exists based on the genotype of B. anthracis isolates
2. The chromosome and plasmid quantity of a vegetative B. anthracis cell is
dependent on genotype and affects an isolates’ virulence.
3. The burning of anthrax infected carcasses contributes the least to the
environmental contamination by B. anthracis spores.
1.4. References
1. 2000. Anthrax, p. 170-180. In OIE Manual of Standards for Diagnostics Tests and
Vaccines. World Organization for Animal Health.
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CHAPTER TWO
ANTIMICROBIAL SUSCEPTIBILITIES OF DIVERSE
BACILLUS ANTHRACIS ISOLATES*
2.1. Introduction
The etiologic agent of anthrax, Bacillus anthracis, is an acute disease of primarily
herbivores, which is transmissible to humans. Susceptible animals are primarily infected
by the spores formed by the vegetative state of the bacteria. Spores may be found in soil
contaminated by diseased animals or in diseased animal products such as hair, wool,
hides, and bones. The importance of treatment of the disease in humans has been
underscored by the bioterrorism events of October 2001 in the United States.
Ciprofloxacin was the antimicrobial of choice for prophylactic treatment after exposure
to the spores of B. anthracis that were used in the bioterrorism events. Penicillin,
traditionally the drug of choice for treatment, is still recommended in other parts of the
world despite reports of penicillin-resistance (3,4). The Centers for Disease Control has
recommended ciprofloxacin, penicillin, and doxycycline for the treatment of human
anthrax and for use as a prophylactic measure prior to and during the October event (2).
In the past streptomycin, penicillin, gentamicin, and chloramphenicol have also been
recommended (7).
Other articles have been written concerning B. anthracis and antimicrobial
susceptibilities, two over ten years ago and one within the past year. The first paper in

* Reprinted by permission of Antimicrobials Agents and Chemotherapy
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1990 by Lightfoot et al. determined the antimicrobial susceptibility of 70 isolates
of B anthracis against penicillin, amoxycillin, cefuroxime, gentamicin, streptomycin,
erythromycin, tretracycline, chloramphenicol, and ciprofloxacin by agar dilution (6).
Penicillin resistance and beta-lactamase production was noted in two isolates. This paper
was quickly followed in 1991 by Doganay and Aydin (3). They tested 22 B. anthracis
isolates against 27 antimicrobial agents by agar dilution and reported 19 isolates showed
resistance to the five 3rd generation cephalosporins tested. The isolates were shown to be
sensitive to the other antimicrobials tested. These two papers were very basic in their
approach and reporting. The latest paper, Mohammad et al, tested 65 isolates with nine
antimicrobial agents using the National Committee for Clinical Laboratory Standards
(NCCLS) broth microdilution method.(7). The results obtained from 50 of the isolates
were compared to the Etest strips. One isolate was penicillin resistant and no statistically
significant difference was found between the broth microdilution, and Etest results.
The two earlier papers distinguished between sensitive and resistant in regards to
the MIC noted for each isolate(3,6). Unfortunately, no basis is given, such as what
standard they used for these designations. The Mohammed et al. paper used the NCCLS
breakpoints for Staphylococcus, which we have also chosen to use to discriminate
between sensitive (S), intermediate (I), and resistant (R). According to the NCCLS
literature, studies for Bacillus spp. are not yet adequate to develop reproducible,
definitive standards to interpret results (8). The infections caused by Staphylococcus spp.
are very similar to the infections caused by B. anthracis. In addition, the distributions of
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the aforementioned antimicrobial data are in line with the Staphylococcus MIC
breakpoints for antimicrobials used in this study.
In this study, we examined 25 genetically diverse isolates of B. anthracis to
determine their susceptibility to seven clinically relevant antimicrobial agents. Etest
strips (AB BIODISK, Solna, Sweden) were used to measure the MICs of the isolates.
2.2. Materials and Methods
2.2.1. Selection of Isolates
A total of 25 isolates diverse in time, space, and genotype were used in this study (Table
2.1). These 25 isolates are a representative subset of 89 distinct genotypes characterized
by multiple locus variable number tandem repeat analysis (5).
2.2.2. Study Design
MICs of seven antimicrobial agents-penicillin, cephalexin, cefaclor, tobramycin,
doxycycline, ciprofloxacin, and cefuroxime-were determined, using the Etest (AB
BIODISK Solna, Sweden) methodology described elsewhere (1). Tryptic soy agar plates
containing 5% sheep blood (Remel) were inoculated with a swab taken from a colony
suspension equal to that of a 0.5 McFarland standard. One Etest strip was placed per
plate after ten minutes. Quality control was assessed using Staphylococcus aureaus
ATCC 29213. The plates were incubated overnight at 37oC and the plates were read at
16 and 24 hours. This was repeated three times for each isolate.
2.2.3. Beta Lactamase Activity
Beta-lactamase activity of each isolate was determined with the use of nitrocefin
disks (BBL), which utilizes a chromogenic cephalosporin. A drop of sterilized water was
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applied to the disk, and then with a loop, a colony was removed from the agar plate and
applied to the disk. The inoculum was taken from an overnight TSA plate for each
isolate. A positive reaction was denoted by the formation of a pink or red color. The
reactions were held for one hour to confirm negative results.

Table 2.1. B. anthracis isolates used by genotype and cluster
Genotype #

Cluster

Country

State/Location

Source

Year isolated

3

A1a

Canada

unknown

bovine

1974

10

A1a

USA

South Dakota

bovine

1996

15

A1a

Poland

Krakow

bovine

1962

20

A1a

Italy

Campania

ovine

1994

23

A1b

Turkey

Yozgat

human

1991

25

A1b

USA

Florida

bovine

1937

28

A1b

Turkey

Sivas

human

1984

29

A2

Pakistan

unknown

ovine

1978

30

A3a

Zambia

Mongu

bovine

1992

34

A3a

South Korea

Kyungjoo

human

1994

35

A3a

Namibia

Etosha Nat'l Park

zebra

1993

38

A3a

Germany

Giessen

porcine

1971

41

A3a

Turkey

Sivas

human

1985

45

A3a

Argentina

Buenos Aires

bovine

1980

51

A3a

USA

Maryland

bovine

1939

55

A3a

Australia

Queensland

bovine

1994

57

A3b

China

Changping

bovine

unknown

62

A3b

USA(Ames)

Texas

bovine

1981

67

A3a

South Africa

Kruger Nat’l Park

Kudu

1993

68

A3d

USA

Ohio

human

1968

69

A4

Pakistan

unknown

wool

1976

77

A4

UK (Vollum)

S. Oxfordshire

bovine

1937

80

B1

France

unknown

bovine

1997

85

B2

Mozambique

Maputo

porcine

1944

87

B2

South Africa

Kruger Nat'l Park

Kudu

1975

14

2.3. Results
The MIC results are summarized in Table 2.2. Using the Staphylococcus MIC
breakpoints all isolates were susceptible to the antimicrobials except for cefuroxime and
penicillin.
Only one isolate, GT 69, was sensitive, five isolates (GT’s 23, 28, 34, 55, 77)
were resistant, and the remaining 19 were categorized as intermediate to cefuroxime.
The MIC90 was 32 µg/ml, which is considered the breakpoint for resistance. The range
for cefuroxime was wide, from 6 – 48 µg/ml.
Of the three recommended antimicrobials for the treatment of anthraxciprofloxacin and doxycycline exhibited potent activity against the B. anthracis isolates.
Twenty-two of the isolates were susceptible to penicillin and three (GT’s 20, 68, 85) were
classified as resistant. None of the isolates examined showed any beta-lactamase activity.
Ciprofloxacin, the drug-of-choice, had an MIC range of 0.032 to 0.38 µg/ml with a MIC
at which 90% of the isolates tested are inhibited (MIC90) of 0.094 µg/ml. This was the
same as the MIC50 and was the most active agent tested. All of the isolates were
susceptible to doxycycline and the other antimicrobials-cephalexin, cefaclor, and
tobramycin.
2.4. Discussion
In this study, we have examined a spatially, temporally, and genetically diverse
group of B. anthracis isolates for susceptibility to seven clinically relevant
antimicrobials. This is the first report to use confirmed genetically diverse field isolates
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(5). Lightfoot et al. used 70 isolates, 33 of which were considered by the authors to be
unrelated(6). Doganay and Aydin used 22 isolates collected from the same region in
Table 2.2. MIC50s and MIC90s with antimicrobial susceptibilities of 25 B. anthracis
isolates.
MIC (µg/ml)

Categorical interpretation
# of isolatesa

AntimicrobialRange

50% 90%

S

Cefaclor

0.125 - 0.75 0.38 1.65

25

Cefuroxime

6 - 48

S

I

R

≤8

16

≥ 32

1

≤8

16

≥ 32

Cephalexin

0.38 - 2

25

≤8

16

≥ 32

Ciprofloxacin 0.032 - 0.38 0.094 0.094

25

≤1

2

≥4

Doxycycline 0.094 - 0.38 0.23 0.34

25

≤4

8

≥ 16

Penicillin

<0.016 - 0.50.042 0.236

22

Tobramycin

0.25 - 1.5

25

a

b

21.33 32
1.5

1.5

0.75 0.97

I

Staphylococcal breakpoints (µg/ml)b

19

R

5

3

≤ 0.12
≤4

≥ 0.25
8

≥ 16

S – susceptible; I – intermediate; R – resistant
NCCLS M100-S12

Turkey within a period of seven years (3). The most recent paper, Mohammed et al.,
used 50 historical isolates and 15 recent isolates (7). The 50 historical isolates collected
between 1937 and 1997 were selected as representatives of temporally and spatially
diverse strains. Together these studies have utilized 182 isolates to test antimicrobial
susceptibilities. Unfortunately, the detailed isolate information from previous studies
could not be obtained and therefore no correlations or comparisons can be made,
genetically, spatially, or temporally.
Cefuroxime is a 3rd generation cephalosporin and is reported to be effective
against gram-positive bacteria. The older studies showed a high rate of resistance with
cefuroxime, though the MIC90s were lower in this study. The MIC90 for the other studies
was 64 µg/ml and for this study, it was 32 µg/ml. This could be an artifact of the
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methodologies or a true difference in the isolates, but in any case, the reason for this
resistance is unknown and the mechanism of the resistance needs to be investigated
further.
Penicillin and ciprofloxacin were also listed in all studies and all showed good
activity against the isolates of B. anthracis. Differences in the MIC90s are noted between
the reports.
Penicillin resistance was reported in two of the other studies. Lightfoot et al.
reported resistance, MIC >0.25 µg/ml, in two isolates which originated from the same
fatal case, and Mohammed et al. reported three resistant isolates including the same
isolate from the Lightfoot et al. study(6,7). Using the Staphylococcus breakpoints, our
study demonstrated three resistant isolates. These isolates were tested for beta-lactamase
production and found to be non-producers as were all the isolates. Since the highest
concentration was within a doubling dilution of the 0.25 µg/ml it is possible that the
Staphylococcus breakpoints are not appropriate for comparison in bacillus species. There
could be other explanations for this observation. Strains of B. licheniformis have been
shown to produce large amounts of a beta-lactamase yet be sensitive to penicillin (9). In
another study, a strain was shown to be highly susceptible to penicillin and still actively
produce a beta-lactamase (10). Penicillin resistance in Bacillus spp. is an area that needs
more research than a cursory susceptibility panel every few years.
Ciprofloxacin, doxycycline and the remaining antimicrobial agents, cefaclor,
cephalexin, and tobramycin, showed all isolates tested highly susceptible. This was in
agreement with the other studies that tested the corresponding antimicrobial agent.
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Now that a reliable genotyping system is available, more genotypes should be
tested against these and other antimicrobials to verify the trends noted here and in other
studies. Beta-lactamase production or non-production should not be considered as an
alternative for testing penicillin resistance. Hopefully this study will contribute to the
impetus for a more thorough study into beta-lactamase production and Bacillus spp.
Continued surveillance of B. anthracis field isolates is recommended to monitor
antimicrobial susceptibility.
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CHAPTER THREE
BACILLUS ANTHRACIS VIRULENCE IN AVA VACCINATED GUINEA PIGS IS
LINKED TO PLASMID QUANTITIES AND CLONALITY
3.1. Introduction
The etiologic agent of anthrax, Bacillus anthracis, is a gram positive, rod-shaped,
spore forming bacterium. The disease primarily affects ungulate herbivores, occasionally
carnivores, and less frequently humans (29). Anthrax is a disease well documented
throughout human history with suggestive reports in the Bible and Sanskrit manuscripts
(5). Koch, Pasteur, and others revolutionized the field of microbiology with their studies
using B. anthracis as a model organism (27). Though anthrax has not been eradicated,
the development of effective animal and human vaccines has reduced its importance for
humans and animals in developed countries over the last century. Recently, however,
anthrax research has become increasingly important due to this pathogen’s central role in
biological warfare and biological terrorism (14). The importance of the disease in
humans has been underscored by the bioterrorism events of October 2001 in the United
States. Therefore, the need for basic techniques that are rapid and reliable, yet exhibit
high specificity have taken on great importance in the development of detection assays.
Identification and detection systems based on real-time quantitative PCR (QPCR)
have been described for several bacteria including B. anthracis (1, 2, 13, 23). These
techniques are easy to design, simple to carry out and are commonly applied to monitor
and detect the microbial status of sample specimens. With proper design and careful
application, diagnostic quantitative PCR systems can be applied to reliably estimate and
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in this case absolutely enumerate target organisms as well as nucleic acid elements within
those organisms, such as plasmids (21).
The virulence of B. anthracis has been associated with two megaplasmids, pXO1
and pXO2 (29) Plasmid pXO2 (60 MDa) carries the genes required for synthesis of an
antiphagocytic poly-D-glutamic acid capsule facilitating host immune system evasion (9,
16, 22, 30, 31, 34). The 110-MDa plasmid pXO1 is required for synthesis of the three
anthrax toxin proteins, edema factor (EF), lethal factor (LF), and protective antigen (PA)
(30). These proteins act in binary combinations to produce the two anthrax toxins: edema
toxin (PA and EF) and lethal toxin (PA and LF) (17). Although the role of capsule and
toxin in disease pathogenesis have been well characterized, copy numbers of these
plasmids have not been investigated (7, 18). Recently, a study has been published
alluding to the copy number of each plasmid per cell of the ‘Ames’ isolate of B. anthracis
(26). While differences have been observed between the virulence of various isolates of
B. anthracis, only a portion of these can be attributed to plasmid related effects (34).
Previous studies have shown that the virulence of B. anthracis can vary between
isolates or strains (6, 8, 20). Some variation in virulence can be related to the presence or
absence of the plasmids. Isolates lacking either the pX01 or pX02 plasmid are
considered either avirulent or significantly attenuated (24, 32). However, this does not
explain the variation in virulence observed in studies comparing fully virulent isolates
such as the Ames and Vollum 1B strains (11, 12) Explanations for these differences in
virulence have never been fully substantiated. Possible mechanisms responsible for the
modulation of virulence exist including copy number of plasmids per cell, transcription
regulation of the anthrax toxins and capsule, and additional variation may be mediated by
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generation time and germination efficiency. These factors are likely associated with
mutations that could be clonally heritable.
In this study, we have shown that B. anthracis virulence is related to clonality and
pXO1 and pXO2 copy number. We chose 20 genetically diverse B. anthracis isolates as
defined by the multi-locus VNTR analysis (MLVA) (89 distinct genotypes and seven
major clusters) and performed survival trials in guinea pigs vaccinated with the current
licensed U.S. human vaccine, anthrax vaccine adsorbed (AVA). Absolute quantitative
PCR analysis was used to determine the plasmid copy number present per cell (pXO1,
pXO2) for each of the isolates. Our model describing the virulence of B. anthracis
isolates in AVA vaccinated guinea pigs using MLVA cluster association, clonality, and
plasmid copy number was then verified using a randomly chosen group of 12 isolates.
3.2. Materials and Methods
3.2.1. Bacterial Isolates
A total of 36 isolates of B. anthracis were included in this study (Table 3.1). All of
these isolates have been previously genotyped using multi-locus VNTR analysis (MLVA)
(Keim). Initially, twenty isolates were chosen for animal challenge studies and plasmid
copy number characterization based upon their representation of genetic diversity from a
worldwide collection. Genetic diversity was determined by MLVA cluster assignment
and was based upon genotypic allele patterns described previously for eight VNTR loci
(15). The isolates used in this study are representative of all seven major MLVA clusters.
Twelve isolates were chosen at random from the worldwide collection that were
previously genetically characterized using MLVA.
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Table 3.1. B. anthracis isolates used by country and cluster with the survival percentage
of AVA vaccinated guinea pigs and the calculated number of plasmids, pXO1 and pXO2.
Ratio of plasmid to chromosome is in parentheses.
Id
Country
Cluster
% Survival pXO1 (rpXO1)
pXO2 (rpXO2)
Model Isolate Set
1
China
A3b
0
185 (30.9)
9 (1.5)
2
Australia
A3a
0
121 (20.2)
32 (5.4)
3
Namibia
A3a
19
242 (40.3)
5 (0.9)
4
Ames
A3b
38
65 (10.8)
2 (0.3)
5
Germany
A3a
25
113 (18.9)
5 (0.9)
6
Turkey
A3a
31
131 (21.8)
11 (1.8)
7
France
B2
31
243 (40.5)
4 (0.6)
8
Turkey
A1b
38
236 (39.4)
27 (4.5)
9
Pakistan
A2
38
120 (20.0)
1 (0.2)
10
South Africa
B1
44
66 (11.0)
2 (0.4)
11
Zambia
A3a
44
242 (40.4)
15 (2.5)
12
Turkey
A1b
44
172 (28.7)
6 (1.0)
13
USA
A3a
44
109 (18.1)
4 (0.7)
14
South Africa
A3b
50
212 (35.3)
16 (2.6)
15
Argentina
A3a
50
104 (17.4)
7 (1.2)
16 Mozambique
B1
75
95 (15.9)
1 (0.2)
17
Canada
A1a
69
24 (40.5)
18 (3.0)
18
USA
A1a
69
128 (21.4)
5 (0.8)
19
Pakistan
A4
75
191 (31.9)
14 (2.3)
20
Vollum
A4
94
69 (11.5)
10 (1.6)
Test Isolate Set
A
Indonesia
A4
13
44.4 (7.4)
4 (0.6)
B
South Korea
A3a
19
62 (10.4)
3 (0.5)
C
USA
A3a
19
89 (14.8)
3 (0.5)
D
South Africa
A4
25
94 (15.6)
11 (1.9)
E
India
A3a
25
33 (5.5)
2 (0.4)
F
USA
A3b
31
44 (7.3)
2 (0.4)
G Mozambique
B1
44
86 (14.4)
10 (1.6)
H
Norway
B1
44
218 (36.3)
1 (0.2)
I
Croatia
B1
44
49 (8.2)
3 (0.5)
J
Canada
A1a
50
83 (13.9)
5 (0.9)
K
USA
A1a
50
65 (10.8)
4 (0.7)
L
USA
A1a
56
115 (19.2)
9 (1.5)
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3.2.2. DNA Preparation
DNA from each isolate was obtained by heat lysis of a single colony. The isolates
were streaked onto blood agar plates and then incubated at 37°C overnight. A single
colony from each plate was transferred into a 0.22 µm microcentrifuge tube containing
200 µl of TE (Tris-HCl [pH 8.0], 1.0 mM EDTA). The colony was resuspended by
repetitive pipetting. The cellular suspension was heated to 95°C for 20 minutes and then
cooled to room temperature. Cellular debris and any possible contamination by spores
were removed by centrifugation at 6,000 x g for 1 min. Centrifugation was conducted
inside a biosafety cabinet to contain any aerosols. The supernatant was then transferred
to a new tube for storage. One microliter of the lysate contained sufficient template to
support a single PCR.
3.2.3. Oligonucleotide Design of Probes and Primers
The loci sequences used for the QPCR assay primer and probe development on the
chromosome, and plasmids pXO1, and pXO2 have previously been published (25).
Probe and primer sequences (Table 3.2) were designed with the software program Primer
Express (Perkin-Elmer, Applied Biosystems, Foster City, Calif.) according to the
manufacturer’s instructions. The sequence of the probe was selected based on previously
described criteria: predicted cross-reactivity to B. anthracis; melting temperature of the
probe at 69°C; lack of predicted dimer formation with corresponding primers and of selfannealing; a 10°C higher melting temperature of the probe than of the primers; and no
stretches of identical nucleotides longer than four and no G at the 5’ end of probe (10).
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The fluorescent reporter dye at the 5’ end of the probe was 6-carboxy-fluorescein (FAM);
the quencher at the 3’ end was 6-carboxy-tetramethyl-rhodamine (TAMRA).
Table 3.2. 5’ nuclease assay primers and probes.
Target

Primers

pXO1 plasmid BApXO1-PR

Amplicon

6FAM-TCGAATTACTAAATCCTGCAGATACACTCCCACC-TAMRA

84 bp

BApXO1-FP

AATGATCAATTGCGACCGTACTT

BApXO1-RP

TGCATGCGTCGTTCTTTGATA

pXO2 plasmid BApXO2-PR

Chromosomal

Sequence (5’-3’)

6FAM-TACTGCTTCTGTACGTTGTACCCATGTCGC-TAMRA

BApXO2-FP

TCACCAACCATCGTCATCGT

BApXO2-RP

CGTTATGTAGCAATCGTATTACCTCTTAT

BA813-PR

6FAM-AATGCCAGGTTCTATACCGTATCAGCAAGCTATTC-TAMRA

BA813-FP

GGAGGGAATACAGCAAACACAGA

BA813-RP

TGCAACTGATGGGATTTCTTTCT

131 bp

123bp

3.2.4. Standard for Absolute Quantitation
Standards for absolute quantitation of each primer/probe grouping (pXO1, pXO2,
BA813) were prepared as follows. The PCR amplified fragment obtained with the
primers for each grouping was cloned using pcDNA3.1/V5-His-TOPO TA and
transformed into Escherichia coli TOPO10 (Topo TA cloning kit; Invitrogen, NV Leek,
The Netherlands). Purification of the plasmid DNA was carried out with a commercial
plasmid DNA isolation kit (Qiagen, Basel, Switzerland). The DNA concentration was
determined with a spectrophotometer and was diluted to 1010 templates/5 µl. Dilutions
were made equivalent to 109, 107, 105, 103, 10 and 1 copy of template per 5 µl. For
bidirectional DNA sequencing of the insert, the forward primer and reverse primer were
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used. The nucleotide sequence was determined using a fluorescence-based automated
sequencing system (ABI 377A DNA sequencer) by Microsynth, Balgach, Switzerland.
The plasmid insert was sequenced to confirm its identity with B. anthracis.
3.2.5. Test of Detection Limit for 5’ Nuclease Assay
The detection limit of the QPCR assays for B. anthracis, was determined by making
serial dilutions of overnight cultures of two isolates, isolate 4 and isolate 17 (Table 3.1),
suspended in 0.9% NaCl. The suspension was adjusted to a density corresponding to that
of a McFarland 1.0 standard and from this serial dilutions were made. Plate counts from
each dilution were performed in triplicate on 5% sheep blood agar (Remel). A total of
200 µl of culture from each dilution was heat lysed as described above, and 5 µl was used
for the 5’ nuclease assay. Each test was repeated three times.
3.2.6. Specificity of the QPCR Assays
Ten isolates of closely related Bacillus spp. were used to examine the specificity of
the QPCR assay. These isolates were B. cereus isolates, ATCC 4381 and ATCC 14579,
B. subtilis ATCC 6051, B. megaterium ATCC 14580 and four confirmed environmental
isolates, and two environmental isolates of B. thuringensis. The environmental isolates
were confirmed by 16S rRNA sequencing.
3.2.7. 5’ Nuclease Assay
Each 25-µl PCR reaction contained 1X TaqMan® Universal PCR Master Mix (Part
number 4304437, Applied Biosystems), 16 µM each primer, 100 nM fluorogenic probe,
and 5 µl of template or plasmid standard. DNA amplification was carried out in
MicroAmp® Optical 96-well reaction plates (part number N801-0560, Applied
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Biosystems) sealed with MicroAmp® optical caps (part number N801-0935, Applied
Biosystems). The cycling program consists of heating for two minutes at 50oC then 10
minutes at 95oC followed by a two stage temperature profile of 95oC for 15 seconds and
60oC degrees for one minute, repeated for 40 cycles. Amplification, data acquisition, and
data analysis were carried out with an ABI 7700 Sequence Detector (Applied
Biosystems). All 5’ nuclease tests were repeated at least three times for all isolates listed
in the tables.
3.2.8. Vaccination and Challenge
All data associated was provided by Patricia F. Fellows, USAMRIID, Ft. Detrick,
Md. Hartley guinea pigs (Charles River, Wilimington, MA) were vaccinated at 0 and 4
weeks intramuscularly (i.m.) with 0.5 ml AVA (Bioport, Michigan, etc.). At 10 weeks
after the first vaccination, the guinea pigs were challenged i.m. with 10,000 spores of
virulent B. anthracis. Survival was noted for 14 days post challenge.
3.2.9. Absolute Copy Number of Loci, Statistical Analysis and Modeling
All means, statistical analyses, and modeling were calculated using SPSSTM version
10.2 software. The mean absolute copy number of chromosomal loci per cell was
determined by back calculation using total number of cells in a series of dilution trials
analyzed with the QPCR assay. Cross-validation of the mean number of plasmid loci per
cell was performed using the same methodology. The mean number of cells per trial
were determined using most probable number methods and confirmed with direct spore
counts. The ratios of plasmid to chromosomal DNA copy were derived by first dividing
the total estimated copy number of chromosomal loci determined using the QPCR assay
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by the mean absolute copy number of chromosomal loci per cell (determined above) then,
dividing the estimated total copies of plasmid loci (for each of the two plasmids
individually) by the adjusted chromosomal copy number.
After assembling the data set and calculating the ratios of plasmids to chromosome
copies, means of the MLVA clusters were estimated concurrent with a one-way analysis
of variance. The percent survival of guinea pigs was modeled using a univariate general
linear model. The dependent variable, percent survival, was modeled with the two
covariates ratio of pXO1 to chromosome (rpXO1) and ratio of pXO2 to chromosome
(rpXO2) and the factor MLVA cluster which had seven levels corresponding to the seven
major MLVA clusters (15). The model examined main effects only of the covariates and
factor. No interactions were examined for the model. Parameter estimates and 95%
confidence intervals were calculated for each covariate, factor level and model intercept
term. Statistical significance levels for evaluation of the model were set a priori at alpha
= 0.05. Post hoc tests were conducted using the Student-Newman-Keuls method.
3.3. Results
3.3.1. Specificity and Sensitivity of the 5’ Nuclease Assay
The three unique primer/probe sets designed for the specific identification and
target quantification of B. anthracis correctly discriminated all isolates tested (Table 3.2).
The analytical sensitivity of the QPCR assays was comparable to that of the previously
described nested PCR (3). The assay system resolution was sufficient to detect one copy
of the standard plasmid. The samples containing no template gave a negative result.
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3.3.2. Chromosome, pXO1, pXO2 Loci per Bacteria and Plasmid Ratios
The average number of chromosomal loci detected per cell was approximately 6
for all of the isolates examined. The number of loci detected per cell for each of the
virulence plasmids, however, varied greatly across isolates, ranging from 33 (isolate E) to
243 (isolate 7 and 17) for pXO1, and from 1 (isolates 9, 16, and H) to 32 (isolate 2) for
pXO2. The plasmid:chromosome loci ratios are listed for each isolate in Table 3.1.
The mean plasmid:chromosome loci ratios calculated over the seven MLVA
clusters were significantly different as indicated by the results of an ANOVA (p<0.05)
(Figure 3.1). Post hoc tests indicated that for pXO1 there were three overlapping groups.
Group 1 included MLVA clusters A2, A3a, A3b, A4 and B1. Group 2 included MLVA
clusters A1, A2, A3a and A3b. Group 3 included MLVA clusters A1 and B2. Post hoc
tests indicated that for pXO2 there were two overlapping groups. Group 1 included
MLVA clusters A2, A3a, A3b, A4, B1 and B2. Group 2 included MLVA clusters A1,
A3a, A3b, B1 and B2.
3.3.3. Vaccination Challenge and Survival
Survival of the vaccinated guinea pigs ranged from 0 to 94 percent. The percent
survival of the vaccinated guinea pigs challenged with each of the isolates used in this
study, are listed in table 3.1. The average survival overall was approximately 40%. The
average time to death was 5 days for all isolates tested and ranged from 3 to 7 days. The
mean percent survival for each MLVA cluster is shown in Figure 3.1. The results of an
ANOVA indicated that the means were different (p<0.05). Post hoc testing showed four
groups, two of which had overlapping membership (Figure 3.2). The most virulent
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MLVA cluster, indicated by lowest survival, had a mean survival of 21.3% (cluster A3b)
and included an isolate of the Ames strain.
3.3.4. Model of Virulence
We analyzed the combined data set of percent survival, ratio of
plasmid:chromosome (rpXO1 and rpXO2) and MLVA cluster assignment using a general
linear univariate model. Overall model statistics indicated that rpXO1 was not a
significant predictor of survival (p>0.05) but that rpXO2 and MLVA cluster were
significant (p<0.05 for both). The parameter estimate obtained for rpXO1 was not
significant however the estimate obtained for rpXO2 was (rpXO1 = 0.06, p>0.05; rPXO2
= -1.93, p<0.05). The magnitude of the parameter estimates obtained for each of the
seven MLVA clusters indicate a much greater influence on survival outcome than either
plasmid ratio ranging from 0.00 (A3b) to 75.41 (A4) (Figure 3.2). As previously
mentioned, post hoc testing revealed two overlapping and two distinct statistical groups
(Figure 3.2) indicating that there are potentially as many as five or as few as three
separate groups among the MLVA clusters. Graphs of the observed and predicted
percent survival for both the isolates with which the model was constructed and a test set
of 12 randomly chosen isolates indicate a good model fit (Figure 3.3). The raw residual
values are also shown for each set of predicted and observed comparison.
Figures 3.1 and 3.2 show a grouping of the MLVA clusters into three distinct
groups. The least virulent group, A4, contains isolates from the United States, Norway,
Europe, and Asia (15). This group also contains ‘Vollum’ which was used in the UK
biological warfare program (15). The middle group is made up of clusters A1 and B1
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and is of medium virulence. Clusters A1 and B1 are similar in virulence but are
geographically diverse. Isolates in the A1 cluster are found predominantly from Wood
Bison National Park (Canada), south to Texas in the United States. Southern African
isolates make up the majority of the B1 cluster (15). The most virulent group consists of
four clusters, A2, A3a, A3b, and B2. This grouping is also geographically diverse. B2 is
found mainly in southern Africa and has been loosely associated with the A cluster (15).
A3a is associated with isolates from around the world especially Turkey and Namibia.
A3b is dominated by isolates from China, yet this cluster also contains ‘Ames.’
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Figure 3.1. Means of plasmid to chromosome ratios and percent survival of AVA
vaccinated guinea pigs by MLVA cluster used to build model.
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Figure 3.2. MLVA cluster model parameter estimates and 95% confidence intervals.
3.4. Discussion
In this study, we have presented results demonstrating that B. anthracis virulence is
related to clonality (as indicated by MLVA genotype cluster) and pXO1 and pXO2 copy
number. By combining data collected from challenge studies of AVA vaccinated guinea
pigs, pXO1 and pXO2 plasmid copy number with a genetically diverse set of isolates we
developed a model predictive of virulence. We then used this model to compare the
predicted and observed survival of AVA vaccinated guinea pigs when challenged with a
randomly chosen set of isolates. It is likely that factors affecting the variation in
virulence we observed are due to mutations that are heritable and clonally passed on to
daughter cells. This could also include a predisposition for stable plasmid copy number
configurations of pXO1 and pXO2.
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with diverse B. anthracis isolates. Twenty isolates were used to construct the model (A)
and an additional set of twelve isolates were used to the test the model (B).
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While we can offer no explanation for the association of higher or lower virulence
with respect to specific MLVA clusters the relationship is plausible from the standpoint
of mutations and clonality. Other examples of genetic typing based group differences in
pathogen virulence have been observed (4). Further investigation to determine the
underlying reasons for variation in virulence should center on the genetic differences
between representative isolates from different MLVA clusters such as A3b and A4, that
showed extreme differences in mean survival and model parameter estimates. Although
rpXO2 was found to be a significant contributor in the virulence model, there was no
distinct difference in the number of plasmids per cell for clusters A3b and A4; therefore,
we can conclude that the differences were due to factors other than the number of
plasmids per cell.
Our observations have revealed tremendous variation in pXO1 and pXO2 copy
number per cell using a genetically diverse collection of isolates. These observations
were made possible by the use of a new method for molecular detection of B. anthracis
using QPCR. Using QPCR, we were able to detect one copy of the standard plasmids for
the chromosome, pXO1, and pXO2. A common belief among the research community
has been that B. anthracis contains only one copy of each plasmid. Here, using a QPCR
method, we have shown that there is more than one copy of each plasmid per cell and that
there is tremendous variation among genetically diverse isolates. Our results indicate that
there may be up to 243 copies of pXO1 and 32 copies of pXO2 per cell. While these
numbers may seem extreme, this could be appropriate because the longer a cell survives
the more toxin it can produce.
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It has long been known that different isolates have exhibited varying levels of virulence
(11, 19, 28). The factors responsible for the different levels of virulence in these isolates
are unknown. We have shown that the number of pXO2 plasmids in each bacterial cell
contributes to the level of virulence associated with that isolate. Although the model that
we developed indicated that pXO1 copy number does not contribute significantly to
virulence, it is likely that in an experimental challenge of unvaccinated animals would
find that the number of copies of pXO1 would also contribute to variations in virulence.
However, the results of our studies presented here indicate that pXO2 plays a significant
role in virulence and can contribute to observed variation in virulence. In the mouse
model, isolates that only contain pXO2 remained lethal at low doses (33). Welkos
showed that the pXO2 plasmid contributes significantly to the virulence of the organism
(32) and that mutants producing greater amounts of capsule exhibited a higher level of
virulence than the parental strain. Figure 3.4 shows an increasing gradation of virulence
associated with an increase of pXO2.
Virulence studies of anthrax are an important source of information especially
considering the organisms use as a bioterror/biowarfare agent. This study has put
forward some interesting and significant information concerning virulence of different
isolates of B. anthracis and the testing of these same isolates in an animal system. Trends
in the data with respect to plasmid copy number have revealed clues that will take us into
the next paradigm of virulence testing. Hypotheses have been suggested that can now be
tested due to technological advances in molecular biology techniques. Additional animal
studies using unimmunized animals utilizing more representative isolates of all clusters
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are recommended to validate the model and cluster effect observed in this study.
Furthermore, validation of the model could lead to its use as a screening tool and
complement vaccine efficacy testing.
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Figure 3.4. Effect of pXO2:genome ratio on percent survival across MLVA clusters
holding pXO1:genome ratio constant.
3.5. References
1. Angen, O., J. Jensen, and D. T. Lavritsen. 2001. Evaluation of 5' nuclease assay
for detection of Actinobacillus pleuropneumoniae. J.Clin.Microbiol. 39:260-265.
2. Bach, H. J., J. Tomanova, M. Schloter, and J. C. Munch. 2002. Enumeration of
total bacteria and bacteria with genes for proteolytic activity in pure cultures and in
environmental samples by quantitative PCR mediated amplification. J
Microbiol.Methods 49:235-245.

36

10

3. Beyer, W., P. Glockner, J. Otto, and R. Bohm. 1995. A nested PCR method for
the detection of Bacillus anthracis in environmental samples collected from former
tannery sites. Microbiol.Res. 150:179-186.
4. Farlow, J., K. L. Smith, J. Wong, M. Abrams, M. Lytle, and P. Keim. 2001.
Francisella tularensis strain typing using multiple-locus, variable- number tandem
repeat analysis. J.Clin.Microbiol. 39:3186-3192.
5. Farrar, W. E. 1995. Anthrax: from Mesopotamia to molecular biology. Pharos
58:35-38.
6. Fellows, P. F., M. K. Linscott, B. E. Ivins, M. L. Pitt, C. A. Rossi, P. H. Gibbs,
and A. M. Friedlander. 2001. Efficacy of a human anthrax vaccine in guinea pigs,
rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of
diverse geographical origin. Vaccine 19:3241-3247.
7. Friedlander, A. M. 2000. Anthrax: clinical features, pathogenesis, and potential
biological warfare threat. Curr.Clin.Top.Infect.Dis. 20:335-349.
8. Friedlander, A. M., S. L. Welkos, M. L. Pitt, J. W. Ezzell, P. L. Worsham, K. J.
Rose, B. E. Ivins, J. R. Lowe, G. B. Howe, and P. Mikesell. 1993. Postexposure
prophylaxis against experimental inhalation anthrax. J.Infect.Dis. 167:1239-1243.
9. Green, B. D., L. Battisti, T. M. Koehler, C. B. Thorne, and B. E. Ivins. 1985.
Demonstration of a capsule plasmid in Bacillus anthracis. Infect.Immun. 49:291297.
10. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time
quantitative PCR. Genome Res. 6:986-994.
11. Ivins, B. E., P. F. Fellows, and G. O. Nelson. 1994. Efficacy of a standard human
anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs. Vaccine
12:872-874.
12. Ivins, B. E., M. L. Pitt, P. F. Fellows, J. W. Farchaus, G. E. Benner, D. M.
Waag, S. F. Little, G. W. Anderson, Jr., P. H. Gibbs, and A. M. Friedlander.

37

1998. Comparative efficacy of experimental anthrax vaccine candidates against
inhalation anthrax in rhesus macaques. Vaccine 16:1141-1148.
13. Jauregui, L. H., J. Higgins, D. Zarlenga, J. P. Dubey, and J. K. Lunney. 2001.
Development of a real-time PCR assay for detection of Toxoplasma gondii in pig
and mouse tissues. J.Clin.Microbiol. 39:2065-2071.
14. Kaufmann, A. F., M. I. Meltzer, and G. P. Schmid. 1997. The economic impact
of a bioterrorist attack: are prevention and postattack intervention programs
justifiable? Emerg.Infect.Dis. 3:83-94.
15. Keim, P., L. B. Price, A. M. Klevytska, K. L. Smith, J. M. Schupp, R. Okinaka,
P. J. Jackson, and M. E. Hugh-Jones. 2000. Multiple-locus variable-number
tandem repeat analysis reveals genetic relationships within Bacillus anthracis.
J.Bacteriol. 182:2928-2936.
16. Keppie, J. P., P. W. Harris-Smith, and H. Smith. 1963. The chemical basis of the
virulence of Bacillus anthracis. IX. Its aggressins and their mode of action.
Br.J.Exper.Pathol. 44:446-453.
17. Leppla, S. H. 1995. Bacterial toxins and virulence factors in disease, p. 543-572.
Marcel Dekker, New York, N.Y.
18. Little, S. F. and B. E. Ivins. 1999. Molecular pathogenesis of Bacillus anthracis
infection. Microbes.Infect. 1:131-139.
19. Little, S. F. and G. B. Knudson. 1986. Comparative efficacy of Bacillus anthracis
live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
Infect.Immun. 52:509-512.
20. Little, S. F. and G. B. Knudson. 1986. Comparative efficacy of Bacillus anthracis
live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
Infect.Immun. 52:509-512.
21. Ludwig, W. and K. H. Schleifer . 2000. How quantitative is quantitative PCR with
respect to cell counts? Syst.Appl.Microbiol 23:556-562.

38

22. Makino, S., I. Uchida, N. Terakado, C. Sasakawa, and M. Yoshikawa. 1989.
Molecular characterization and protein analysis of the cap region, which is essential
for encapsulation in Bacillus anthracis. J Bacteriol. 171:722-730.
23. Makino, S. I., H. I. Cheun, M. Watarai, I. Uchida, and K. Takeshi. 2001.
Detection of anthrax spores from the air by real-time PCR. Lett.Appl.Microbiol
33:237-240.
24. Mikesell, P., B. E. Ivins, J. D. Ristroph, M. H. Vodkin, T. Drier, and S. Leppla.
2002. Plasmids, Pasteur, and Anthrax. ASM News 49:320-322.
25. Ramisse, V., G. Patra, H. Garrigue, J. L. Guesdon, and M. Mock. 1996.
Identification and characterization of Bacillus anthracis by multiplex PCR analysis
of sequences on plasmids pXO1 and pXO2 and chromosomal DNA. FEMS
Microbiol.Lett. 145:9-16.
26. Read, T. D., S. L. Salzberg, M. Pop, M. Shumway, L. Umayam, L. Jiang, E.
Holtzapple, J. D. Busch, K. L. Smith, J. M. Schupp, D. Solomon, P. Keim, and
C. M. Fraser. 2002. Comparative genome sequencing for discovery of novel
polymorphisms in Bacillus anthracis. Science 296:2028-2033.
27. Turnbull, P. C. 1991. Anthrax vaccines: past, present and future. Vaccine 9:533539.
28. Turnbull, P. C., M. G. Broster, J. A. Carman, R. J. Manchee, and J. Melling.
1986. Development of antibodies to protective antigen and lethal factor components
of anthrax toxin in humans and guinea pigs and their relevance to protective
immunity. Infect.Immun. 52:356-363.
29. Turnbull, P. C. B. and J. M. Kramer. 1995. Bacillus, p. 349-356. In P. R.
Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (eds.), Manual
of Clinical Microbiology. ASM Press, Washington, D.C.
30. Uchida, I., K. Hashimoto, and N. Terakado. 1986. Virulence and
immunogenicity in experimental animals of Bacillus anthracis strains harbouring or
lacking 110 MDa and 60 MDa plasmids. J.Gen.Microbiol. 132 ( Pt 2):557-559.

39

31. Uchida, I., J. M. Hornung, C. B. Thorne, K. R. Klimpel, and S. H. Leppla.
1993. Cloning and characterization of a gene whose product is a trans- activator of
anthrax toxin synthesis. J.Bacteriol. 175:5329-5338.
32. Welkos, S. L. 1991. Plasmid-associated virulence factors of non-toxigenic (pX01-)
Bacillus anthracis. Microb.Pathog. 10:183-198.
33. Welkos, S. L., Becker, D, Friedlander, A, and Trotter, R. Pathogenesis and host
resistance to Bacillus anthracis: a mouse model. Turnbull P.C.B. Salisbury Medical
Bulletin 68[Special Supplement], 49-52. 1990. Salisbury, Wiltshire, Salisbury
Medical Society. 4-11-1989.
34. Welkos, S. L., N. J. Vietri, and P. H. Gibbs. 1993. Non-toxigenic derivatives of
the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid
pX02 and chromosome in strain- dependent virulence. Microb.Pathog. 14:381-388.

40

CHAPTER FOUR
BACILLUS ANTHRACIS SPORE CONCENTRATIONS AT
VARIOUS CARCASS SITES
4.1. Introduction
Anthrax, an acute bacterial disease of primarily herbivores, is
transmissible to humans. The etiologic agent, Bacillus anthracis, is a gram-positive
spore forming rod shaped bacterium. Animals become infected by ingesting spores or
possibly by being bitten by flies that have fed on an infected animal or carcass (8).
Infected animals are usually found dead as death can occur within 24 hours. (25).
It is generally thought that B. anthracis is an obligate pathogen and that little
propagation occurs in soil (4, 5, 12). With the exception of scavengers, anthrax is almost
never transmitted directly from victim to victim but is rather ingested by herbivores while
grazing or browsing. In such a model, the environmental spore reservoir becomes very
important to the ecology and evolution of this pathogen. Survival in the soil is crucial for
initiating subsequent anthrax epidemics.
Although environmental contamination with B. anthracis spores occurs because
of wildlife and domestic livestock cases, the degree or level of contamination from each
case is unknown. Anthrax spores are known to persist in the environment for years and
are resistant to environmental factors (20). Spores may be found in soil contaminated by
diseased animals or in diseased animal products such as hair, wool, hides, and bones (2).
To prevent or decrease the number of spores contaminating an area, several
methods of carcass disposal have been suggested and utilized. These methods, including

41

incineration, burial, or rendering of the carcass, are recommended with no scientific data
to back them. Once a site becomes seeded with spores, the disease becomes enzootic or
at a constant risk of a persistent series of outbreaks, and sporadic occurrences of the
disease occur in susceptible animals (24). The Office International Des Epizooties (OIE)
and World Health Organization (WHO) Anthrax Guidelines recommend incineration of
infected carcasses as the most desirable method of disposal followed by rendering and
deep burial of the carcass after covering it with quicklime (1, 14, 21).
Spores are known to survive in the environment for years (19). The worldwide
distribution of anthrax and the difficulty encountered in combating it is because of the
marvelous tenacity of the anthrax spore (17). Spores prepared by Pasteur in 1888 were
found to be viable 68 years later. Bones recovered in the Kruger National Park and
estimated by carbon dating to be 200±50 years old are reported to have yielded B.
anthracis on culture (4). Recent studies on the ecology of anthrax have reported a
correlation between the disease and specific soil factors, such as alkaline pH, high
moisture, and high organic content (16, 22, 23). Review of the properties of spores of B.
anthracis suggests that the specific soil factors linked to epidemic areas reflect important
environmental conditions that aid the anthrax spores in causing epidemics (5).
A search of the literature shows little work has been done to ascertain the level of
contamination from a carcass regardless of the manner of carcass disposal, and only three
studies have been done concerning contamination from anthrax infected carcasses.
Dragon et al. collected environmental samples from known burial and cremation sties in
Wood Buffalo National Park and Mackenzie Bison Sanctuary in the Northwest
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Territories of Canada after several epizootics had occurred in the region over the past ten
years. Another study was conducted in the Etosha National Park, Namibia, by Lindeque
et al (12). The park leaves all carcasses exposed on the surface therefore, there was not a
disposal method comparison but they did look at spore levels in soil contaminated by the
body fluids of animals that had died of anthrax. The Etosha study also detected B.
anthracis in scavenger feces and water.
Turnbull et al. described a case in North Devon, England, where two
ponies died in the field in which they had been grazing in 1986 (19). The ponies were
disposed of by rendering and an investigation of how they may have become infected led
to the discovery that a young bull had died of anthrax around 1938 and had been buried
in the field. A bacteriological survey of the field in 1991 revealed isolates could be
recovered from the immediate area which corresponded to the burial site of the bull. This
area was surveyed again in 1992 with the same results. After two unsuccessful efforts at
chemical disinfection with formalin being pumped into the ground and applied to the
surface a decision was made to place a concrete cap, 9m X 5m X 20 cm, over the burial
site to provide a permanent barrier between viable spores and humans or animals.
The samples obtained for these 3 studies ranged in time from immediately after
death to 50 years later. The time between death and sampling for this study ranged from
two to thirteen months. The sampling sites where these samples were taken were diverse
in disposal method and environment. They included carcasses that had been left exposed
on the surface to be scavenged and to decay with time, buried, burned and some were a
combination of these methods. The environment from which these samples were
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collected, ranged from the far North to the South, Wood Buffalo National Park (WBNP)
in the Northwest Territories of Canada; Washoe County, Nevada; and Cuidad Acuna,
Mexico, directly across the border from Del Rio, Texas.
Nothing definitive exists in the literature quantifying or comparing environmental
contamination by carcass disposal methods. To study the risks of the environmental
contamination posed by anthrax infected carcass disposal methods, the soil around
carcasses which had been treated by the different recommended disposal methods was
sampled. Utilizing methods to concentrate the B. anthracis spores found in a soil sample
and extracting the DNA from these spores for identification, it was possible to use
statistical methods to determine the efficacy of the disposal methods.
4.2. Materials and Methods
4.2.1. Site Selection
The locations were selected based on the carcass disposal method employed.
Sampling sites were selected on accessibility and consisted of a confirmed anthrax
carcass that had been left exposed, buried, and/or burned. Once the site was selected, a
sampling area was created.
4.2.2. Surface Soil Sampling
A survey stake was driven into the ground directly over the buried carcass or in
the center of the sampling area. Using the stake as the center, a five-meter radius circle
was marked off using flags. With the use of a compass, the cardinal directions, north,
south, east and west, were marked with a red flag at north and pink flags at the other
directions (Appendix 1). The boundary of the circle was marked with a different colored
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flag. The flags broke the circle into quadrants and five random samples were selected in
each quadrant by tossing five tennis balls into the quadrant and taking 10 cm core
samples with a Hoffer soil sampler where each ball had landed. The approximate
location of each sample was noted on the data collection diagram with the sample
number. Twenty surface samples were collected at each site. The soil sampler was
cleaned with a sporacide between sites.
4.2.3. Deep Core Soil Sampling
Burial sites were sampled using a mud auger and the appropriate extensions. One
deep core hole was made per buried carcass site. The soil was collected in the auger, and,
as the auger would fill with soil, it was removed and the soil collected in a separate
container and marked with the depth and site information. Soil collecting continued until
the buried carcass was reached and tissue was recovered. The sampling equipment was
cleaned with a sporacidal solution between sites.
4.2.4. Spore Concentration Method
From each soil sample collected, 4 grams of soil was placed into a 50ml
centrifuge tube. To the sample, 30 ml of a wash solution (1.22 gm/ml sucrose,
0.5%Triton X-100) was added. The sample was then vortexed and placed on a shaker for
30 minutes. The top 3ml was transferred to a tube containing 6 ml of BSA/PBS (bovine
serum albumin, with phosphate buffered saline, pH 7.4 [PN: P3688 Sigma Chemical
Company, St. Louis, Mo.]), vortexed and centrifuged (6000 g) for 10 minutes. The
supernatant was discarded, 5 ml of 90% ethanol was added to the pellet, vortexed, and
placed on a shaker for 30 minutes. The sample was centrifuged (6000 g) for 10 minutes,
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the supernatant was discarded, and the pellet was resuspended in 1ml of the BSA/PBS
solution. Samples were stored at 4oC.
4.2.5. DNA Extraction Method
In a 2 ml bead-beater tube (BioSpec Products,Inc., Bartlesville, Okla.) containing
900 mg of a mixture of glass beads (450 mg each of 425-600 µm and 106 µm and finer
glass beads [Sigma Chemical Company, St. Louis, Mo., or BioSpec Products,Inc.,
Bartlesville, Okla.]) and 0.5 ml of 2X TENS buffer (1X TENS is 50 mM Tris HCl [pH
8.0], 20 mM EDTA, 100 mM NaCl, 1% [wt/vol] sodium dodecyl sulfate [SDS]), 0.5 ml
of liquid product from the spore concentration method was added. The tubes were
incubated at 70oC for 30 minutes, removing the samples every 10 minutes to vortex.
Samples were homogenized for three minutes at 5,000 rpm in a mini-beadbeater-8 cell
disruptor (catalog no. 693; BioSpec Products,Inc., Bartlesville, Okla.) and were then
centrifuged at 12,000 X g for 10 min at 4oC to pellet the bead mix. The supernatant
containing DNA was collected into a 15 ml centrifuge tube and stored on ice. Under a
vented safety hood, 1 ml of chloroform:isoamyl alcohol (24:1 volume/volume) was added
to the 15 ml tube and placed on a tube rocker for 20 minutes, then centrifuged at 7000 X
g at 4o C for 10 minutes. The upper aqueous phase of the mixture was transferred to a
sterile micro-centrifuge tube and Rnase (1 µg/ml or 1:100) was added, inverted by hand
to mix, and incubated at 37oC for 1 hour. Under a vented safety hood, an equal volume
(500 µl) of chloroform:isoamyl alcohol (24:1 volume/volume) was added and the sample
was placed on a tube rocker for 20 minutes, then centrifuged at 7000 X g at 4o C for 15
minutes. The upper aqueous phase of the mixture was transferred to a sterile micro-
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centrifuge tube, and 0.6 volumes of isopropyl alcohol was added, then inverted by hand
to mix. The samples were frozen at -20o C from 2 hours to overnight, and the nucleic
acids were precipitated by centrifugation at 4000 X g for 5 minutes. The supernatant was
carefully poured off, and the DNA was washed with 500 µl 70% ethanol and centrifuged
at 800 X g for five minutes to re-pellet. The supernatant was carefully poured off, and
the pellet briefly dried. The pellet was dissolved in 500 µl sterile 1XTE buffer (10 mM
Tris pH 7.6, 1 mM EDTA). Samples were stored at -80oC.
4.2.6. Control Soil
Soil from Falaise lake, Northwest Territories, Canada, was used for a control
study. One kilogram of the soil was sterilized by autoclaving at 121oC for 30 minutes on
the wrapped cycle. Sterility was verified by mixing 0.1 gm of the sterile soil with 10 ml
of nutrient broth and incubating at 37oC. The broth was checked for growth every 24
hours for three days with no growth noted. Four grams of sterile soil and unsterile soil
was spiked with 100, 500, 1000, and 10000 spores of B. anthracis in triplicate. These
controls were processed through the spore concentration and DNA extraction methods.
From the 1 ml liquid product of the spore concentration method, 100 µl was plated on
sheep blood agar (SBA, [Remel, Inc.]) in triplicate for all samples. After overnight
incubation at 37oC, the plates were removed and colonies of B. anthracis were counted
and recorded.
4.2.7. Miscellaneous Environmental Samples
Samples other than soil were collected in the area of the sampling site. These
samples included parts of the carcasses, flies, carnivore scat, and water. These samples
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were processed through the spore concentration method. From the 1 ml liquid product of
the spore concentration method, 10 µl was plated on SBA. This was done in triplicate for
all miscellaneous samples. After overnight incubation at 37oC, the plates were removed
and visually inspected for colonies of B. anthracis. All suspect colonies were subcultured onto SBA, and a 5 µl drop of B. anthracis specific gamma phage was applied for
confirmation. After overnight incubation, at 37oC the plates were inspected for a clear
zone where the gamma phage had been applied indicating phage sensitivity. The gamma
phage sensitive isolates were sub-cultured onto a nutrient agar slant and were placed in
the incubator at 37oC for four weeks which allowed for full sporulation and drying of the
agar, then stored at room temperature.
4.2.8. Spore Viability
Random samples from the WBNP 2000 and Nevada soil samples were selected
and from the liquid product of the spore concentration method, 10 µl was plated on SBA.
This was done in triplicate for all selected samples. After overnight incubation at 37oC,
the plates were removed and visually inspected for colonies of B. anthracis. All suspect
colonies were sub-cultured onto SBA, and a 5 µl drop of gamma phage was applied for
confirmation. After overnight incubation at 37oC, the plates were inspected for a clear
zone where the gamma phage had been applied indicating phage sensitivity. The number
of positives was recorded.
4.2.9. Oligonucleotide Design of the Probe and Primers
PCR primer sequences for loci on the chromosome, plasmids pXO1, and pXO2
have previously been published (15). These primers were used as the basis of the primers
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and probes developed for the TaqMan assays (Table 4.1). The TaqMan probe and the
primer sequences were designed with the software program Primer Express (PerkinElmer, Applied Biosystems, Foster City, Calif.) according to the manufacturer’s
instructions. The sequence of the probe was selected based on previously described
criteria (9): predicted cross-reactivity to B. anthracis, melting temperature of the probe at
69°C; lack of predicted dimer formation with corresponding primers and of selfannealing; a 10°C higher melting temperature of the probe than of the primers; and no
stretches of identical nucleotides longer than four and no G at the 5’ end of probe. The
fluorescent reporter dye at the 5’ end of the TaqMan probe was 6-carboxy-fluorescein
(FAM); the quencher at the 3’ end was 6-carboxy-tetramethyl-rhodamine (TAMRA).
Table 4.1. 5’ nuclease assay primers and probes
Target

Primers

pXO1 plasmid BApXO1-PR

Sequence (5’-3’)

Amplicon

6FAM-TCGAATTACTAAATCCTGCAGATACACTCCCACC-TAMRA

84 bp

BApXO1-FP

AATGATCAATTGCGACCGTACTT

BApXO1-RP

TGCATGCGTCGTTCTTTGATA

pXO2 plasmid BApXO2-PR

6FAM-TACTGCTTCTGTACGTTGTACCCATGTCGC-TAMRA

BApXO2-FP

TCACCAACCATCGTCATCGT

BApXO2-RP

CGTTATGTAGCAATCGTATTACCTCTTAT

Chromosomal BA813-PR

6FAM-AATGCCAGGTTCTATACCGTATCAGCAAGCTATTC-TAMRA

BA813-FP

GGAGGGAATACAGCAAACACAGA

BA813-RP

TGCAACTGATGGGATTTCTTTCT
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131 bp

123bp

4.2.10. Plasmid Standard for Absolute Quantitation
A plasmid standard for absolute quantitation of each primer/probe grouping
(pXO1, pXO2, BA813) was prepared as follows. The fragment obtained with the primers
for each grouping was cloned using pcDNA3.1/V5-His-TOPO TA and transformed into
Escherichia coli TOPO10 (Topo TA cloning kit; Invitrogen, NV Leek, The Netherlands).
Purification of the plasmid DNA was carried out with a commercial plasmid DNA
isolation kit (Qiagen, Basel, Switzerland). The DNA concentration was determined with a
spectrophotometer and was diluted to 1010 templates/5 µl. Dilutions were made
equivalent to 109, 107, 105, 103, 10 and 1 copy per 5 µl. For bidirectional DNA
sequencing of the insert, the forward primer and reverse primer were used. The
nucleotide sequence was determined using a fluorescence-based automated sequencing
system (ABI 377A DNA sequencer) by Microsynth, Balgach, Switzerland. The plasmid
insert was sequenced to confirm its identity with B. anthracis.
4.2.11. Quantitative PCR Assay
Each 25-µl Quantitative PCR (QPCR) reaction contained 1X TaqMan® Universal
PCR Master Mix (Part number 4304437, Applied Biosystems), 16 µM each primer, 100
nM fluorogenic probe, and 9 µl of template or 5 µl of plasmid standard. DNA
amplification was carried out in MicroAmp® Optical 96-well reaction plates (part
number N801-0560, Applied Biosystems) sealed with MicroAmp® optical caps (part
number N801-0935, Applied Biosystems). The cycling program consisted of heating for
two minutes at 50oC, then 10 minutes at 95oC, followed by a two stage temperature
profile of 95oC for 15 seconds and 60oC degrees for one minute, repeated for 40 cycles.
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Amplification, data acquisition, and data analysis were carried out with an ABI 7700
Sequence Detector (Applied Biosystems). All QPCR tests were repeated at least four
times for each sample tested.
4.2.12. Statistical Analysis
All means, statistical analyses, and modeling were calculated using SPSSTM
version 11.0.1 software. After assembling the dataset, the means of the QPCR results for
each sample was calculated. Descriptive statistics, bivariate correlations, univariate
general linear models, and linear regression analyses were performed. Statistical
significance levels were set a priori at alpha = 0.05.
4.3. Results
4.3.1. Site Selection
A total of 77 sites were sampled (Table 4.2). No disposal method was used in
WBNP; all of the carcasses were left exposed on the surface. Mixtures of disposal
methods were utilized in Nevada. Six of the sites were of single carcasses that had only
been burned, two sites consisted of one carcass each that had been burned and then
buried, 14 were buried only, 15 were buried with lime poured over the carcass before
backfilling and one carcass was limed and left exposed on the surface. The five cases in
Mexico were all burned.
4.3.2. Soil Sampling
A total of 1538 surface and 241 burial soil samples were collected and worked
through the spore concentration and DNA extraction protocols (Table 4.2.). The overall
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mean for the surface samples was 1.5 x 107 spores and 2.5 x 107 for the burial samples.
The difference was not statistically significant (p=0.792).

Table 4.2. Location of samples with types and number of samples collected.
Sites
Surface
Deep Core
Miscellaneous
Location
Sampled
Samples
Samples
Samples
WBNP 2000

19

388

0

90

WBNP 2001

15

300

0

0

Nevada

38

760

241

58

Cuidad
Acuna, Mexico

5

100

0

17

Totals

77

1538

241

165

4.3.3. Control Soil
A comparison of the CFU counts and QPCR results is shown in Figure 4.1. These
results revealed a Pearson correlation coefficient of .974, (p<0.05) for the sterile and
unsterile soil and a linear relationship (r2 = .949).
4.3.4. Miscellaneous Environmental Samples
Miscellaneous samples were collected from WBNP, Nevada, and Mexico (Table
4.2). No isolates were recovered from the 17 miscellaneous samples collected in Mexico,
possibly because the carcasses were completely burned within hours of finding them.
The samples collected from the WBNP and Nevada sites revealed many positives, 64.5%
and 37.5% respectively (Figure 4.2.). Out of all the samples tested, the scat from both
locations showed the highest percentage of recovery, 72% from WBNP and 42% from
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Nevada. The scat samples were from wolf (Canis lupis) and black bear (Ursus
americanus) in WBNP and coyote (Canis latrans) in Nevada and showed the highest
1000000
# Spores Spiked
cfu Count/4gm
QPCR Count/4gm
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Spores Spiked

10000

1000
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10

1
1

2

3

4

Sample ID

Figure 4.1. A comparison of B. anthracis CFU’s on sheep blood agar and QPCR
absolute counts with the number of spores spiked in sterile and unsterile soil.
levels of contamination per recovery plate. Most of the SBA plates revealed high
numbers of B. anthracis colonies with low contamination from other bacteria.
All of the water samples from WBNP and half of the Nevada water samples tested
positive. These water samples were taken from near a carcass and within the sampling
area.
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The carcass samples consisted of swabs of body fluids, tissue samples, hair,
hooves, and bone. These samples were intimately associated with the carcass, yet the
yield of recovery was low, only 53% for WBNP and 33% from the Nevada carcasses.

35
30

# Nev Samples
# Nev Positive

25

# WBNP Samples
# WBNP Positive

20
15
10
5
0
carcass

scat

water

log

flies

Figure 4.2. Miscellaneous environmental samples taken from sites in Wood Buffalo
National Park, Canada, and Nevada.
4.3.5. Spore Viability
Figure 4.3 is a graphical comparison of the CFU and QPCR results normalized to
1000 µl. This 1000 µl is the product of the spore concentration method with four grams
of soil. The Pearson correlation coefficient between the CFU’s and QPCR was positive
(0.326, p=0.017) indicating a linear relationship. A linear trendline was calculated and
overlaid for each line on Figure 4.3 to further point out the linear relationship between the
colony counts and QPCR results. A linear regression analysis revealed that the lower
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threshold of sensitivity was 7500, meaning there must be at least 7500 pXO1 copies
before viable spores can be recovered.
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Figure 4.3. Comparison of colony forming units on sheep blood agar and quantitative
PCR.
4.3.6. Test of Detection Limit for Quantitative PCR Assay
The analytical sensitivity of the TaqMan PCR was comparable to that of the
previously described nested PCR (2). The assay system detected one copy of the
standard plasmid. The samples containing no template gave a negative result. The
amplification of a plasmid standard dilution over nine 10-fold dilutions showed linearity
over the whole range.
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4.4. Discussion
Research methods have been a limiting factor to the isolation of B. anthracis from
environmental samples. Bacteriological studies have been performed on a very small
scale because of the difficulty of spore isolation involving environmental samples
because of contamination by other soil organisms (6, 18). The spore concentration
method developed for this study utilized the hydrophobic and specific gravity properties
of the spore and showed a clear correlation between plate counts and quantification by
PCR. This study has shown that large scale environmental bacteriological examination
for B. anthracis is now possible. These improved methods have enabled the first
analyses of carcass sites in regards to environmental contamination, disposal method
comparison, and decay over time of B. anthracis.
The assessment of the environmental contamination by carcasses and scavenging
was complex. Scavenging of the carcasses did contribute to the environmental
contamination with numbers frequently high and potentially able to produce new foci of
infection (21). Levels of anthrax spores in scavenger feces depend largely on the state of
anthrax sporulation in the carcasses as vegetative B. anthracis probably do not survive
transit through the digestive system of the scavengers (7, 10).
Environmental contamination by the carcass was observed by both soil and
miscellaneous samples. The miscellaneous samples were surprising as a higher
percentage of positives were expected since the samples were intimately associated with
the carcass. Factors that could have affected the sporulation and the spores is that an
acidic environment produced by a decaying body inhibits the vegetative bacteria from
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sporulating (25). It has been shown that only a small proportion of bacilli released from a
carcass by hemorrhage, natural and otherwise caused, sporulate successfully.
Temperature, moisture, and UV radiation are also known to affect sporulation of B.
anthracis (3, 11, 13). These factors, along with rain, wind, and snow, could also affect
the spores over time.
Considering these factors, a significant difference was detected (p=0.17) between
the samples taken from WBNP in 2000 and 2001 (Figure 4.4).

Mean QPCR over samples

30,000,000

20,000,000

10,000,000

0
WBNP 2000

WBNP 2001

Time Decay

Figure 4.4. Difference in QPCR counts over time in Wood Buffalo National Park in the
years 2000 and 2001.
The samples were taken one year apart at the same sites sampled in 2000. The time
between death and sampling also proved to be significant (p=0.13) (Figure 4.5). This
decrease in spores over time was also noted at carcass sites in the Etosha National Park.
The differences seen here address the need to widen the sampling to include sites from
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historical anthrax areas, present outbreak sites, and a time series over these sites sampling
at regular quarterly intervals.

Mean QPCR over samples

30,000,000

20,000,000

10,000,000

0
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13

Time (months)

Figure 4.5. Difference in QPCR counts between time of death and time of sampling.

When separating the sites by locality within the region, a significant difference
(p=0.001) was noted (Figure 4.6). The differences noted here could be caused by many
factors such as soil, rain, and other environmental factors. The two regions with the
highest counts, Lake One Delta and the 91–92 Site, are very different in that the 91-92
Site localities have not had a known anthrax case since 1992, while the Lake One Delta is
an area where some of the first cases are found and the last cases in the area were
reported in 2001. Another difference between theses locals is the 91-92 Sites are burial
sites of an unknown number of buried carcasses and the Lake One Delta is a low lying
area that drains into a lake. Only surface samples were taken at both locals, and isolates
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were recovered from both in the range of 1000 per ml. The reason for the high counts
associated with the 91-92 Sites is unknown, but speculation could involve the surface
contamination by the buried carcasses. A resampling of this burial site including deep
samples would be informative and may give clues as to where the spores are coming
from.

Ge ogra phic l ocatio n
W BNP
Nevada
Mexico

7.50E+07

5.00E+07

Andrea Jackson
Cuidad Acuna

Damonte Ranch
91-92 site
Deep Hole Ranch

0.00E+00

Franks Creek
Lake Claire Delta
Lake One Delta
Bella Vista Ranch

2.50E+07

Anthrax Meadow
Rat Creek
Brousse au Creek

Mean QPCR over samples

1.00E+08

Figure 4.6. Comparison of mean QPCR of samples from localities by region.

The purpose of this study was to determine if there was a difference in the
environmental contamination by the different carcass disposal methods, nothing, burned,
or buried, by themselves or in combination. Statistically, there was not a difference using
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the method of disposal and the mean QPCR (p=0.965) in the environmental
contamination from each disposal method. A statistically significant difference is seen
between the method of disposal and the mean CFU per ml (p=0.013). Burning the
carcass did prove statistically significant (p=0.044) when compared to leaving the carcass
exposed with no treatment but was not statistically significant from the other methods of
burying the carcass with or without lime before backfilling (Figure 4.7). The p values for
the other two methods, buried and buried with lime, was 0.05, indicating that they were
the same as leaving the carcass exposed to the environment. Figure 4.8 demonstrates the
reason that no difference was significant between buried, buried with lime, and burned,
the 95% confidence intervals for these methods each contain the other.
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Figure 4.7. Mean of the colony forming units per milliliter from the spore extraction
compared to the method of disposal.
A clearer difference between disposal methods would no doubt become evident
with more sampling. These samples should be taken over more sites from areas not
represented here, and, as stated before, time-series sampling would lend more to the
argument of a difference existing.
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Figure 4.8. 95% confidence intervals of the CFU per milliliter and the method of carcass
disposal.
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CHAPTER FIVE
GENERAL DISCUSSION AND CONCLUSIONS

5.1. Discussion of the Results
Three major studies concerning the properties of B. anthracis are discussed in this
document. Each study revealed some new and exciting discoveries. These studies
also provided information which made us pause and want to ask more questions.
They also showed how little we know about the antimicrobial susceptibilities,
lethality, dispersion, and survival of B. anthracis.
Antimicrobial susceptibility testing for B. anthracis has only previously been
reported three times (2, 8, 10). These reports together tested 182 isolates for
antimicrobial susceptibilities and unfortunately did not include enough detail about
the isolates to make a comparison except by species. This study utilized 25 isolates
of B. anthracis that are diverse in space, time, and genetics, and was reported as such
in hopes that the results will be more relevant to later studies.
A comparison of the results between studies did show similarities in
susceptibilities to most of the antimicrobials tested, such as ciprofloxacin,
doxycycline, cefaclor, cephalexin and tobramycin. It was also noted that with
cefuroxime, a 3rd generation cephalosporin, differences were noted between the
studies. The older studies showed a higher rate of resistance than the present study
which could be a reflection of different methodologies or a difference in the isolates
used (2, 8). The methods used in these older studies utilized agar dilution which has
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been shown to have a high correlation with the E-test method (10, 12). The
differences noted are probably because of different isolates, and unless more testing is
done, this will remain a theory.
Penicillin resistance was noted in this study and has been reported by other
investigators (2, 8, 16).
Beta-lactamase production is a questionable issue with B. anthracis. Penicillin
resistant isolates have been found to be non-producers, and penicillin sensitive
isolates have been shown to actively produce beta-lactamase (13). A theory is that all
B. anthracis carry the beta-lactamase gene but expression is suppressed (16).
The anthrax research community has believed there was only one of each
plasmid, pXo1 and pXO2, since the discovery of the plasmids in 1985 (6). With the
use of new technologies in molecular detection, we have shown that there is more
than one copy of each plasmid per cell and that there is tremendous variation among
genetically diverse isolates. Though the chromosome did not reflect the variation in
loci seen with the plasmids, the numbers could be appropriate from a biochemical and
virulence viewpoint.
An assumption exists that pXO1 contributes the most to the organisms virulence.
The model we developed indicated that pXO1 copy number does not contribute
significantly to virulence but that pXO2 plays a major role in virulence and is a
contributor to the observed variation in virulence. These results would agree with
previous studies that showed that mutants producing greater amounts of capsule were
more virulent (17).
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Another profound observation from this study was that anthrax virulence is
related to clonality as indicated by MLVA genotype cluster (7). The variation in
virulence we observed are likely caused by mutations that are heritable and clonally
passed on to daughter cells. This phenomenon of virulence related clonality has been
associated with the cause of Rabbit Fever, Francisella tularensis (1, 5, 11).
Such a large scale study of the environmental contamination caused by a carcass,
directly and indirectly, has not been attempted before this study. Studies on a much
smaller scale have been reported, but none have compared disposal methods (3, 9,
15). The study reported here compared carcass that had been left exposed on the
surface to decompose over time, buried, burned, and some were a combination of
these. To accomplish this comparison, unique methods were developed to isolate B.
anthracis spores and to extract DNA on a large scale.
This study with its unique methods and samples had to have checks and balances
to validate the protocols and results. These consisted of a comparison between CFU
counts on SBA and the QPCR results, a QPCR detection limit study and spore
viability.
The test of the detection limit for the 5’ nuclease assay found the system detected
one copy of the standard plasmid, and the samples containing no template gave a
negative result. This sensitivity was needed for the comparison of the CFU counts to
the QPCR and the spore viability tests.
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Spiking sterile and unsterile control soils revealed a clear correlation between the
CFU counts and the QPCR results. This gives credibility to the spore’s viability
found within the field samples and to the study as a whole.
One of the most surprising results was the finding of no difference between the
overall means of the surface soil samples (1.5 x 107 spores) and the burial soil
samples (2.5 x 107 spores). This could have been caused by the method of
backfilling, spore movement from the carcass to the surface, or the backfill dirt being
grossly contaminated. Other causes could be postulated, but, until more samples are
collected and analyzed from various burial sites, it seems that burial is a method that
only disguises the contamination - out of sight, out of mind.
One of the questions for this study was the extent of environmental contamination
by scavengers. These samples were represented by carnivore scat that was collected
within 25 meters of a carcass or burial site. Most likely because the carcasses in
Mexico were completely burned within hours of finding the carcass, no isolates were
recovered.
Minimum infectious dose (MID) estimates established by British biological
warfare work in the early 1940s found that the dose needed to ensure lethal infection
by the oral route in sheep, horses, and cattle was 5 x 108 spores (16). Of the 25 scat
samples collected from WBNP, 18 were positive for viable B. anthracis. From these
positive samples, a third produced half of this MID in just four grams. Since on
average the scat weighed over 20 grams, scavengers could be a source by potentially
producing new foci or infection.
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Only five of the 12 scat samples collected in Nevada were positive and only one
of these produced enough spores to potentially produce a new focus of infection. The
difference to be pointed out here is that the carcasses in WBNP were left exposed to
be scavenged and the majority of carcasses in Nevada were buried. In Nevada, the
one sample that had a high recovery was from a site where the carcass had been left
exposed on the surface.
The objective for the soil study was to ascertain which carcass disposal method
contributed the least to environmental contamination. Unfortunately the answer to
this question was not readily apparent from the data.
No difference between the methods of disposal and environmental contamination
when comparing the QPCR results was noted, but there was a difference when
comparing the disposal method with the CFU counts per milliliter. This difference is
attributed to the fact that the DNA is still detectable even if the spore or bacteria have
been rendered non-viable. This has been demonstrated with autoclaved material
including B. anthracis spores and vegetative bacteria (4).
Using the CFU results, a definite difference was noted between the disposal
method, especially between burning and doing nothing to the carcass. Though the
difference between burning and burying was not statistically significant, an inspection
of the CFU count data reveals that the burned carcasses in Mexico did not produce
any isolates and the burned carcasses in Nevada did produce a mean of 3 x 103
CFU/ml. This difference could be attributed to the time lapse between discovery of
the carcass and burning. The carcasses in Mexico were found within hours of death
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and burned within hours of being found, and the Nevada cases were not discovered
until the following day after death and then were not burned until the next day after
discovery.
The time lapse difference between these locations is probably caused by the
difference in man power and regulations. The ranch in Mexico has range riders who
ride the pastures every day and know the cattle and their habits. These range riders
can tell where the cattle are within a few meters at any time of day. This ranch also
has the means and manpower available to burn carcasses immediately after they are
found. In Nevada there was only the ranch manager who was unable to continually
check on the cattle. When a dead cow was found, the ranch manager would have to
call in the veterinarian who would send samples into the state diagnostic laboratory.
If anthrax was confirmed, the state and federal veterinarians were contacted, and a
decision had to be made on how to dispose of the carcass. This would leave one to
believe that our own bureaucracy is helping to contaminate the environment.
5.2. Future Studies
More studies need to be done involving isolates that have been genotyped with
the same method. Though there was no association noted between antimicrobial
susceptibility and MLVA genotype, surely if more representatives of all 89 genotypes
were tested, a pattern would emerge.
The antimicrobial susceptibility study revealed that all isolates of a species are not
alike and should not be judged so. When testing the 25 isolates with doxycycline,
two isolates did show resistance. Unfortunately this could not be verified on retest

70

with the same lot of E-test strips of doxycycline and tetracycline as these two isolates
where shown to be susceptible. Upon inspection of the recently published B.
anthracis genome and discussion with the author revealed that B. anthracis does
carry the tetracycline resistance gene (14).
Another issue associated with antimicrobial studies is beta-lactamase production.
This, too, should be considered to verify if beta-lactamase production is associated
with penicillin resistance in B. anthracis.
An association was definitely demonstrated between the MLVA clusters and
virulence in AVA vaccinated guinea pigs. The virulence model used to compare the
predicted and observed virulence of the isolates needs to be tested on a much wider
dataset, such as the 89 genotypes as defined by MLVA (7). Using animals that are
unimmunized with a full representative dataset of the 89 genotypes would validate the
model and cluster effect.
Since these studies were performed, a new generation of technology has evolved
capable of absolute quantitative PCR. Verification of the chromosome and plasmid
copy numbers is suggested using the primers and probes presented here and other
primers that target different areas of the chromosome and plasmids.
More samples from various locations utilizing various methods of carcass
disposal are needed. These samples should include surface and burial soil and
miscellaneous environmental samples. Background surface soil samples also need to
be collected. These samples would consist of random sites not associated with
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anthrax carcasses. These samples would provide insight into the question of the
ubiquitous distribution of the B. anthracis organism.
These sampling efforts will generate hundreds - if not thousands - of samples.
The plating effort to ascertain B. anthracis isolate recovery is very labor intensive and
requires trained personnel to select the probable Bacillus colonies. The results would
indicate that more isolate recovery is required. A better and more streamlined
procedure needs to be developed to determine spore viability.
Adapting the methods, spore concentration, DNA extraction, and viability to
robotic technology is suggested. This would greatly reduce the personnel and labor
involved, accelerate the laboratory process, and provide results quickly and
efficiently.
5.3. Conclusions
The results of this research have contributed greatly to the knowledge base of B.
anthracis. Additions to the antimicrobial susceptibility database with genotype
knowledge will possibly help with gene identification involved in resistance. The
virulence model is an important tool for the screening of isolates and vaccine testing.
This is truly a paradigm in virulence testing.
The methodologies and insights gained from the soil study have provided the
background and direction needed to realize the importance of such studies. They
have provided an impetus to continue the effort of trying to understand the ecology
and life cycle of B. anthracis.
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